Overview

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Status:
Recruiting
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
Trial to evaluate the efficacy and safety of nitazoxanide in the treatment of colds due to enterovirus/rhinovirus infection
Phase:
Phase 3
Details
Lead Sponsor:
Romark Laboratories L.C.
Treatments:
Nitazoxanide